 In addition, Mesa Labs has granted the underwriters a 30-day option to purchase up to 90,000 additional shares. The offering is expected to settle on June 12, 2020, subject to customary closing conditions. Mesa Labs intends to use the net proceeds from the offering for general corporate purposes, which may include acquisitions. 